Macaques Vaccinated with Simian Immunodeficiency Virus SIVmac239Δnef Delay Acquisition and Control Replication after Repeated Low-Dose Heterologous SIV Challenge

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Virology

• Publication date

  2010-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.00041-10PMID 20592091PMCID PMC2937616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection

  2009cited by this paper
• Faculty Opinions recommendation of Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.

  2009cited by this paper
• Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge

  2009cited by this paper
• Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1

  2009cited by this paper
• Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

  2009cited by this paper
• Effector-memory T cell responses are associated with protection of rhesus monkeys from mucosal SIV challenge

  2009cited by this paper
• Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate

  2009cited by this paper
• Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

  2009cited by this paper
• Vaccine Protection by Live, Attenuated Simian Immunodeficiency Virus in the Absence of High-Titer Antibody Responses and High-Frequency Cellular Immune Responses Measurable in the Periphery

  2008cited by this paper
• Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men

  2008cited by this paper
• Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

  2008cited by this paper
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

  2008cited by this paper
• Macaques vaccinated with live-attenuated SIV control replication of heterologous virus

  2008influential reference
• Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication

  2007cited by this paper
• Fc receptor but not complement binding is important in antibody protection against HIV

  2007cited by this paper
• Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication

  2007cited by this paper
• No Evidence for Consistent Virus-Specific Immunity in Simian Immunodeficiency Virus-Exposed, Uninfected Rhesus Monkeys

  2007cited by this paper
• Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

  2006cited by this paper
• Induction of a virus-specific effector–memory CD4+ T cell response by attenuated SIV infection

  2006cited by this paper
• The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape

  2006cited by this paper
• Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques

  2006cited by this paper
• The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

  2006cited by this paper
• Potential public health impact of imperfect HIV type 1 vaccines.

  2005cited by this paper
• Mucosal effector memory T cells: the other side of the coin

  2005cited by this paper
• HIV vaccine design: insights from live attenuated SIV vaccines

  2005cited by this paper
• Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques

  2005cited by this paper
• Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques.

  2005cited by this paper
• Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

  2005cited by this paper
• Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS

  2005cited by this paper
• Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.

  2005cited by this paper
• Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays

  2004cited by this paper
• Central memory and effector memory T cell subsets: function, generation, and maintenance.

  2004cited by this paper
• Identification of Seventeen New Simian Immunodeficiency Virus-Derived CD8+ T Cell Epitopes Restricted by the High Frequency Molecule, Mamu-A*02, and Potential Escape from CTL Recognition1

  2004cited by this paper
• Repeated Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge Results in the Same Viral and Immunological Kinetics as High-Dose Challenge: a Model for the Evaluation of Vaccine Efficacy in Nonhuman Primates

  2004cited by this paper
• Expression of the Major Histocompatibility Complex Class I Molecule Mamu-A*01 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

  2003cited by this paper
• Escape in One of Two Cytotoxic T-Lymphocyte Epitopes Bound by a High-Frequency Major Histocompatibility Complex Class I Molecule, Mamu-A*02: a Paradigm for Virus Evolution and Persistence?

  2002cited by this paper
• Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

  2002cited by this paper
• Mamu-A*01 Allele-Mediated Attenuation of Disease Progression in Simian-Human Immunodeficiency Virus Infection

  2002cited by this paper
• Diversity Considerations in HIV-1 Vaccine Selection

  2002cited by this paper
• Mechanisms of protection induced by attenuated simian immunodeficiency virus.

  2002cited by this paper
• Persistence of Pathogenic Challenge Virus in Macaques Protected by Simian Immunodeficiency Virus SIVmacΔnef

  2001cited by this paper
• Neutralization Synergy of Human Immunodeficiency Virus Type 1 Primary Isolates by Cocktails of Broadly Neutralizing Antibodies

  2001cited by this paper
• Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

  2001cited by this paper
• A Commonly Recognized Simian Immunodeficiency Virus Nef Epitope Presented to Cytotoxic T Lymphocytes of Indian-Origin Rhesus Monkeys by the Prevalent Major Histocompatibility Complex Class I Allele Mamu-A*02

  2001cited by this paper
• Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine

  2000cited by this paper
• Evidence for Recombination of Live, Attenuated Immunodeficiency Virus Vaccine with Challenge Virus to a More Virulent Strain

  2000cited by this paper
• Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

  2000cited by this paper
• Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

  1999cited by this paper
• Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge

  1999cited by this paper
• Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

  1999cited by this paper
• Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1

  1998cited by this paper
• Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239

  1997cited by this paper
• Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum.

  1997cited by this paper
• Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus

  1997cited by this paper
• Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa.

  1997cited by this paper
• Vaccine protection by a triple deletion mutant of simian immunodeficiency virus

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.

  1995cited by this paper
• Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

  1992cited by this paper

• Innate protection against intrarectal SIV acquisition by a live SHIV vaccine

  2024influential citation
• Mucosal immune stimulation with HSV-2 and polyICLC boosts control of viremia in SIVΔNef vaccinated rhesus macaques with breakthrough SIV infection

  2020cites this paper
• Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome

  2020influential citation
• Current advances in HIV vaccine preclinical studies using Macaque models.

  2019cites this paper
• Mamu-B*17+ Rhesus Macaques Vaccinated with env, vif, and nef Manifest Early Control of SIVmac239 Replication

  2018cites this paper
• Monkey Models and HIV Vaccine Research.

  2018cites this paper
• A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products

  2018cites this paper
• Display of the HIV envelope protein at the yeast cell surface for immunogen development

  2018cites this paper
• Controlling Multicycle Replication of Live-Attenuated HIV-1 Using an Unnatural Genetic Switch.

  2017cites this paper
• Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

  2017cites this paper
• Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques

  2017cites this paper
• Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

  2016cites this paper
• Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV

  2016influential citation
• Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection

  2016cites this paper
• Investigation of HIV cure strategies in vivo in BLT humanized mice

  2016cites this paper
• High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques

  2016cites this paper
• Rectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIVΔnef Vaccination

  2016cites this paper
• Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies

  2016cites this paper
• Signatures in Simian Immunodeficiency Virus SIVsmE660 Envelope gp120 Are Associated with Mucosal Transmission but Not Vaccination Breakthrough in Rhesus Macaques

  2015cites this paper
• A discrete-time survival model with random effects for designing and analyzing repeated low-dose challenge experiments.

  2015cites this paper
• CD8 T Cell Response Maturation Defined by Anentropic Specificity and Repertoire Depth Correlates with SIVΔnef-induced Protection

  2015cites this paper
• The role of chance in primate lentiviral infectivity: from protomer to host organism.

  2015cites this paper
• Analysis of repeated low‐dose challenge studies

  2015cites this paper
• Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif

  2015cites this paper
• Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models

  2015cites this paper
• Correction: CD8 T Cell Response Maturation Defined by Anentropic Specificity and Repertoire Depth Correlates with SIVΔnef-induced Protection

  2015cites this paper
• Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study

  2015cites this paper
• Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING

  2015cites this paper
• The influence of delivery vectors on HIV vaccine efficacy

  2014cites this paper
• the Path of Virus Entry Antibody Production and Concentration on Vaccine Correlate of Protection: Local Live Simian Immunodeficiency Virus

  2014cites this paper
• Vaccination against Endogenous Retrotransposable Element Consensus Sequences Does Not Protect Rhesus Macaques from SIVsmE660 Infection and Replication

  2014cites this paper
• CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge

  2014cites this paper
• Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus

  2014cites this paper
• Live Simian Immunodeficiency Virus Vaccine Correlate of Protection: Local Antibody Production and Concentration on the Path of Virus Entry

  2014cites this paper
• Mucosal Priming with a Replicating-Vaccinia Virus-Based Vaccine Elicits Protective Immunity to Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

  2013cites this paper
• Location and Dynamics of the Immunodominant CD8 T Cell Response to SIVΔnef Immunization and SIVmac251 Vaginal Challenge

  2013cites this paper
• Acute-Phase CD8 T Cell Responses That Select for Escape Variants Are Needed to Control Live Attenuated Simian Immunodeficiency Virus

  2013cites this paper
• Evaluating Human Endogenous Retrovirus and LINE-1 Retrotransposable Element Antigens as Novel Targets for T cell Based HIV-1 Vaccine Strategies

  2013cites this paper
• Statistical Investigation of the Immune Response in Non-Human Primate Models

  2013cites this paper
• SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans

  2013cites this paper
• Influence of Mismatch of Env Sequences on Vaccine Protection by Live Attenuated Simian Immunodeficiency Virus

  2013cites this paper
• Heterogeneity in Neutralization Sensitivities of Viruses Comprising the Simian Immunodeficiency Virus SIVsmE660 Isolate and Vaccine Challenge Stock

  2013cites this paper
• Live Attenuated Rev-Independent Nef¯SIV Enhances Acquisition of Heterologous SIVsmE660 in Acutely Vaccinated Rhesus Macaques

  2013cites this paper
• Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates

  2013cites this paper
• Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques

  2013cites this paper
• A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge.

  2012cites this paper
• Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines

  2012cites this paper
• Loss of a Tyrosine-Dependent Trafficking Motif in the Simian Immunodeficiency Virus Envelope Cytoplasmic Tail Spares Mucosal CD4 Cells but Does Not Prevent Disease Progression

  2012cites this paper
• Control of Innate and Adaptive Immune Responses during Infectious Diseases

  2012cites this paper
• Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

  2012cites this paper
• The genetic architecture of schizophrenia: new mutations and emerging paradigms.

  2012cites this paper
• T Cell Responses During Human Immunodeficiency Virus (HIV)-1 Infection

  2012cites this paper
• The Role of Exposure History on HIV Acquisition: Insights from Repeated Low-dose Challenge Studies

  2012cites this paper
• Randomization inference and principal stratification in HIV prevention studies

  2012cites this paper
• Protection against High-Dose Highly Pathogenic Mucosal SIV Challenge at Very Low Serum Neutralizing Titers of the Antibody-Like Molecule CD4-IgG2

  2012cites this paper
• New paradigms for HIV/AIDS vaccine development.

  2012cites this paper
• Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic

  2012cites this paper
• Significant Protection against High-Dose Simian Immunodeficiency Virus Challenge Conferred by a New Prime-Boost Vaccine Regimen

  2011cites this paper
• The TRIM5α Genotype of Rhesus Macaques Affects Acquisition of Simian Immunodeficiency Virus SIVsmE660 Infection after Repeated Limiting-Dose Intrarectal Challenge

  2011cites this paper
• Living in a house of cards: re‐evaluating CD8+ T‐cell immune correlates against HIV

  2011cites this paper
• Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.

  2011cites this paper
• Strategies to enhance the potency of HIV-1 DNA vaccines

  2011cites this paper
• Mechanisms and Factors that Influence High Frequency Retroviral Recombination

  2011cites this paper
• Vaccine Protection against Simian Immunodeficiency Virus in Monkeys Using Recombinant Gamma-2 Herpesvirus

  2011cites this paper
• HIV-1 Replication in Langerhans and Interstitial Dendritic Cells Is Inhibited by Neutralizing and Fc-Mediated Inhibitory Antibodies

  2010cites this paper
• Immunogenic Retrotransposable Elements Is Safe and Infection-associated Endogenous Vaccination with Cancer-and Hiv Vaccination with Cancer-and Hiv Infection-associated Endogenous Retrotransposable Elements Is Safe and Immunogenic Materials and Methods Serv-k Ag Constructs Primary Abs In-gel Digestio

  year unknowncites this paper
• Reproducing SIVnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines

  year unknowncites this paper
• CD 40 L-Adjuvanted DNA / Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV 239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE 660 Mucosal Challenge

  year unknowncites this paper
• Immunogenic Retrotransposable Elements Is Safe and Infection-associated Endogenous Vaccination with Cancer-and Hiv

  year unknowncites this paper